The second annual BioCrossroads New Venture Competition presented by Krieg DeVault will be accepting submissions for the 2013 competition at the end of May.  Finalist presentations to a panel of expert life sciences, health information technology and venture capital industry judges on Monday, October 21, 2013. The winning new venture will be announced at an awards presentation held that evening at the Indiana Life Sciences Summit networking reception.   The purpose of the competition is to encourage life sciences and healthcare entrepreneurial activity by providing awards and recognition to promising new life sciences and health information technology ventures. 

Applying companies will enter a highly competitive process to gain access to key industry contacts and cash awards, as well as gain access to ISF II staff and the fund’s network of resources to provide early-stage strategic support to the companies.

Companies in the Life Sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology sectors that hold a substantial nexus to Indiana and a high potential for attracting investment capital should apply.    

The competition will be comprised of an initial application submission, invitation of highly-scored applications to submit full business plans, semi-finalists selection and interviews and the selection of five finalists to present to a panel of expert judges and compete for the first, second and third-place prizes. The pre-venture prize will be selected from a pool of applications that is deemed interesting technology, but too developmentally early to advance to the semi-final round.